Clinical Study
Association of Maternal Age to Development and Progression of Retinopathy of Prematurity in Infants of Gestational Age under 33 Weeks
Table 1
Univariate analyses of risk factors for developing any stage of ROP in gestational age <33 weeks infants.
| Variable | Without ROP () | Any stage of ROP () | value | Odds ratio | 95% CI |
| Gestational age (weeks)† | 31.1 (29.3–32.0) | 26.7 (25.5–28.3) | | 0.474 | 0.386–0.584 | Birth weight (g)† | 1356 (1057–1635) | 761 (596–919) | | 0.995 | 0.993–0.996 | Maternal age (years)† | 33 (30–37) | 31 (28–35) | | 0.924 | 0.869–0.984 | SGA (, %) | 26 (27) | 36 (43) | | 2.077 | 1.114–3.872 | Apgar score; 1 min† | 6 (4–8) | 3 (1–6) | | 0.735 | 0.647–0.834 | Apgar score; 5 min† | 8 (6–9) | 6 (4–8) | | 0.651 | 0.548–0.774 | Multiple birth (, %) | 28 (29) | 20 (24) | 0.467 | 0.781 | 0.401–1.521 | Gender; Male (, %) | 56 (57) | 39 (46) | 0.149 | 0.650 | 0.362–1.168 | Pulmonary surfactant (, %) | 32 (33) | 54 (64) | | 3.713 | 2.008–6.862 |
|
|
CI: confidence interval; ROP: retinopathy of prematurity; SGA: small for gestational age. . Median (interquartile range).
|